Plain-English translation of NCT05540938 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Rheumatoid Arthritis research guide →Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing whether , a traditional Chinese medicine preparation, can help people with rheumatoid arthritis achieve deeper remission (better control of their disease) when added to their standard medications. You would already be taking two standard arthritis drugs—methotrexate and tofacitinib—and this study looks at what happens when the medication is added to that routine.
Many people with rheumatoid arthritis continue to have some disease activity even on standard treatments. Researchers want to see if combining traditional Chinese medicine with these standard drugs can help patients reach a deeper level of remission and better long-term outcomes.
You likely qualify if…
You likely don't qualify if…
You would continue taking your regular methotrexate and tofacitinib medications. Half of participants will also take (the active medication), while the other half will take a placebo that looks and tastes the same but contains no active ingredient. You will take your assigned treatment three times daily for three months and likely have regular clinic visits to monitor how you're doing and assess whether your arthritis is improving.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
China